James Neal - 09 Jan 2025 Form 4 Insider Report for Akari Therapeutics Plc (AKTX)

Role
Director
Signature
/s/ Torsten Hombeck, as Attorney-in-Fact
Issuer symbol
AKTX
Transactions as of
09 Jan 2025
Transactions value $
$4,800
Form type
4
Filing time
10 Jan 2025, 17:30:04 UTC
Previous filing
26 Dec 2024
Next filing
10 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKTX Ordinary Shares, par value $0.0001 per share Award $4.8K +8M +33.04% $0.00 32.2M 09 Jan 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares.
F2 On January 9, 2025, the Reporting Person acquired 8,000,000 Ordinary Shares at a purchase price of $0.00065 per Ordinary Share.